Filing
2nd Quarter - Report
Lobbying activity
2
Issues related to drug pricing, legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog
Issues related to drug pricing, legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog